TUE 20 OCTMorning8:38 AM

Back to the brief

BIZCNBC

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

Read the original report

Opens CNBC in a new tab